USPTO serial 97305795
CELLE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SENSOR, JAMES EARL
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CELLE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Daniel R. Frijouf
Daniel R. Frijouf FRIJOUF, RUST & PYLE, P.A.4601 N. Armenia AvenueTAMPA, FL 33603United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations comprising exosomes for use in scientific research, industry and science; Biological preparations comprising exosomes for use in the manufacture of pharmaceuticals for treating wounds, cancers and neurodegenerative, cardiovascular, hematological, inflammatory, autoimmune, pulmonary and orthopedic diseases; human blood for scientific and medical research use; Cord blood for scientific and medical research use; Stem cells for research and scientific purposes | ACTIVE | — |
| 005 | Cell parts in the nature of exosomes for medical purposes; biological preparations comprising exosomes for the treatment of wounds, cancers and neurodegenerative, cardiovascular, hematological, inflammatory, autoimmune, pulmonary and orthopedic diseases; human blood for medical purposes; blood plasma; cord blood for medical purposes; stem cells for medical purposes | ACTIVE | — |
| 044 | Medical services, namely, infusion therapy services; Medical services, namely, cord blood infusion services, stem cell infusion services; Medical services, namely, stem cell transplantation, stem cell therapy and stem cell treatment services; Blood, organ, and tissue bank services for human blood, human umbilical cord blood, human umbilical cord blood stem cells, mesenchymal stem cells, human menstrual stem cells, birth tissue, placentas and human tissue for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use; collection and preservation of human blood, menstrual blood, and umbilical cord blood, for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use; Collection of umbilical cord stem cells, mesenchymal stem cells, menstrual stem cells, birth tissue, placentas and human tissue for medical, therapeutic, biotechnological, cosmetic and pharmaceutical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cryo-Cell International, Inc.
- Other trademarks owned by Cryo-Cell International, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named CELLE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 5, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 5, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 11, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 11, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 5, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 4, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 2, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 2, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 2, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 4, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 4, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 4, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 4, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 28, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 28, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 25, 2024 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Oct 25, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Oct 25, 2024 | PETG | PETITION TO REVIVE-GRANTED | — |
| Oct 25, 2024 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Oct 7, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 7, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 5, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 13, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 13, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 12, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 9, 2024 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Apr 9, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Apr 9, 2024 | PETG | PETITION TO REVIVE-GRANTED | — |
| Apr 9, 2024 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Apr 8, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 8, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 5, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 5, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 11, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 11, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 21, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 5, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 5, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 5, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 5, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 2, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 1, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 1, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 2, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 2, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 2, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 26, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 26, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 26, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 16, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 16, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 16, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 11, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 15, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 14, 2022 | NWAP | NEW APPLICATION ENTERED | — |